06.08.2018 – 09:11 Stada ArzneimittelPress release - STADA becomes Majority Shareholder of BIOCEUTICALS Arzneimittel AG - CEO Claudio Albrecht: "Excellent basis for further strong growth in the biosimilar segment" Press release STADA becomes Majority Shareholder of BIOCEUTICALS Arzneimittel AG CEO Claudio Albrecht: "Excellent basis for further strong growth in the biosimilar segment" Bad Vilbel, August 6, 2018 - After repurchasing the rights to Hedrin® from ... One documentmore
20.07.2018 – 10:55 Stada ArzneimittelPress release - STADA Launches Anti-Cancer Drug Pemetrexed Press release STADA Launches Anti-Cancer Drug Pemetrexed Bad Vilbel, July 20, 2018 - STADAPHARM GmbH, the subsidiary of STADA Arzneimittel AG focused on specialty pharmaceuticals, will from now on distribute cytostatic drug Pemetrexed STADA®. The drug is used for treating locally advanced, metastasized and non-small cell lung cancer and is a generic of ... One documentmore
